Qian Chu
Academic / Other · 6 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Durvalumab as Consolidation for Patients LS-SCLC Small Cell Lung Cancer Limited Stage | Phase 2 | 2026-02-24 |
| Recruiting | Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC） NSCLC, Neoadjuvant Therapy | — | 2025-12-01 |
| Recruiting | Symptoms Burden in Lung Cancer Patients Undergoing Definitive Chemoradiotherapy: Insights From Electronic Pati Lung Cancer, Chemoradiotherapy, Patient-Reported Outcomes (PRO) | — | 2024-06-01 |
| Recruiting | Cadonilimab (AK104) Plus Chemotherapy as First-line Treatment in Non-squamous Non-Small Cell Lung Cancer (NSCL Carcinoma, Non-Small-Cell Lung | Phase 2 | 2023-08-07 |
| Recruiting | Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinom Sarcomatoid Carcinoma of Lung | Phase 2 | 2021-07-19 |
| Completed | A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC) NSCLC | — | 2019-07-12 |